Skip to main content

Nadofaragene firadenovec Disease Interactions

There is 1 disease interaction with nadofaragene firadenovec.

Moderate

Nadofaragene firadenovac (applies to nadofaragene firadenovec) immunosuppression

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency

Nadofaragene firadenovac is a non-replication adenoviral vector-based gene therapy. Patients who are immunocompromised or immunodeficient may be at risk for disseminated adenovirus infection. Avoid exposure to this drug in those patients.

References

  1. (2022) "Product Information. Adstiladrin (nadofaragene firadenovec)." Ferring Pharmaceuticals Inc

Nadofaragene firadenovec drug interactions

There are 286 drug interactions with nadofaragene firadenovec.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer